Inventor · disambiguated record
Antonius Ter Laak
Also filed as: TER LAAK ANTONIUS · TER LAAK ANTONIUS M
13 granted patents·21 pending applications·69 citations·filing 2002–2021
86Inventor score
Top patents by PatentIndex Score
34 records- 0190US7977325B23-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2005·Granted Jul 12, 2011·31 cites·15 claims
- 0286US6790858B2Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormoneZENTARIS AG·Filed 2002·Granted Sep 14, 2004·34 cites·19 claims
- 0371US9708311B2Benzimidazole derivatives as EP4 antagonistsBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·2 cites·10 claims
- 0470US7795264B2Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Sep 14, 2010·1 cites·23 claims
- 0566US9655887B2Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraceptionBayer Pharma AG·Filed 2014·Granted May 23, 2017·1 cites·19 claims
- 0660US2024287048A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 0751US7378522B2Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormoneZENTARIS AG·Filed 2004·Granted May 27, 2008·0 cites·13 claims
- 0851US2024279207A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 0947US2010029599A1Indolylamides as modulators of the EP2 receptorBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1046US2010029598A1Extended Benzamide Derivatives as Modulators of the EP2 ReceptorBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1145US7842809B2Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of sameBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 30, 2010·0 cites·25 claims
- 1244US2008125435A11-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioureas as modulators of the EP2 receptorBRAUER NICO·Filed 2007·Application pending·0 cites
- 1343US12357603B2Acyl sulfonamides for treating cancerBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 1443US2009042913A1Indolylalkylthienopyrimidylamines as modulators of the EP2 receptorBRAEUER NICO·Filed 2008·Application pending·0 cites
- 1543US2009042878A1Thienopyrimidylamines as modulators of the ep2 receptorBRAEUER NICO·Filed 2008·Application pending·0 cites
- 1642US2009023738A1Diaminopyrimidines as modulators of the ep2 receptorBRAEUER NICO·Filed 2008·Application pending·0 cites
- 1742US2020085791A1[(phenylsulfonyl)octahydro-epiminoisoindol-yl](1h-1,2,3-triazol-5-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1841US9062041B22H-indazoles as EP2 receptor antagonistsBAYER IP GMBH·Filed 2012·Granted Jun 23, 2015·0 cites·9 claims
- 1940US11161825B24-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamidesBAYER AG·Filed 2018·Granted Nov 2, 2021·0 cites·13 claims
- 2040US2008125463A1N-(1-hetarylpiperidin-4-yl)(het)arylamides as EP2 receptor modulatorsBRAEUER NICO·Filed 2007·Application pending·0 cites
- 2140US2006167035A1Quinoline derivative, its use, production and pharmaceutical agents containing the latterSCHWEDE WOLFGANG·Filed 2005·Application pending·0 cites
- 2240US2015080438A16,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 2339US2008146576A1N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulatorsBRAEUER NICO·Filed 2007·Application pending·0 cites
- 2438US2009023741A1Aryl/hetarylamides as modulators of the ep2 receptorBUCHMANN BERND·Filed 2008·Application pending·0 cites
- 2538US2009042882A1Substituted acetamides as modulators of the ep2 receptorBUCHMANN BERND·Filed 2008·Application pending·0 cites
- 2637US10167293B2[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Granted Jan 1, 2019·0 cites·18 claims
- 2737US2020123147A1Thiazole compounds useful as prmt5 inhibitorsBAYER AG·Filed 2018·Application pending·0 cites
- 2837US2020079758A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2936US10654818B2Furane derivatives as inhibitors of ATAD2Bayer Pharma AG·Filed 2016·Granted May 19, 2020·0 cites·14 claims
- 3036US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 3135US2020087284A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1, 2, 3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3228US10023539B2Aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2015·Granted Jul 17, 2018·0 cites·14 claims
- 3328US2018118722A1Novel aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2016·Application pending·0 cites
- 3426US2018099937A1Novel aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonius Ter Laak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →